Tuesday 17 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Deals & M&A

Merck KGaA agrees to buy Rapid Micro Biosystems for 75 cents a share

The German group plans to fold the Growth Direct maker into its life science arm, with completion pencilled in for December, subject to enough shareholders tendering.

16 Nov 2026 · Rapid Micro Biosystems, Inc. RPID · Company news

Merck KGaA of Darmstadt, Germany, has agreed to acquire Rapid Micro Biosystems, paying $0.75 in cash for each share. The two companies signed the contract on 16 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Company's press release (SEC filing): Rapid Micro Biosystems, Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More Deals & M&AAll →